Arax Advisory Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.3K | Sell |
|
|||||
|
2025
Q1 | $59.3K | Buy |
|
|||||
|
2024
Q4 | $72K | Buy |
|
|||||
|
2024
Q3 | $35.7K | Buy |
|
|||||
|
2024
Q2 | $27.9K | Buy |
|
|||||
|
2024
Q1 | $26.3K | Hold |
|
|||||
|
2023
Q4 | $22.9K | Hold |
|
|||||
|
2023
Q3 | $19K | Hold |
|
|||||
|
2023
Q2 | $20.4K | Hold |
|
|||||
|
2023
Q1 | $19.6K | Sell |
|
|||||
|
2022
Q4 | $24.4K | Hold |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $35K | Buy |
|